About

Who We Are

Orgo Pharma & Fuels is a dynamic and emerging Limited Liability Partnershipfirm, incorporated on November 9th, 2021 registered with the Registrar ofCompanies in Delhi, the company is classified as a non-government entitywith a strategic focus on the pharmaceutical sector, Orgo Pharma & Fuels isdedicated to establishing itself as a key player in the production of ActivePharmaceutical Ingredients (APIs).

Our upcoming state-of-the-art manufacturing facility is strategically located inVillage Urjani, Tehsil Chhachhrauli, District Yamunanagar, Haryana. Thisfacility is poised to contribute significantly to the pharmaceutical industry witha planned production capacity of 100 metric tons per month, encompassing 18diverse API products.

At Orgo Pharma & Fuels, we are committed to maintaining the highest standards of quality, safety, and environmental sustainability in our operations. Our mission is to meet the growing demands of the healthcare sector with innovative and reliable solutions, while ensuring the well-being of the communities we serve. Backed by a team of seasoned professionals and a forward-thinking management approach, Orgo Pharma & Fuels LLP is set to make a meaningful impact in the pharmaceutical manufacturing landscape of India.

Objective:

The demand for pharmaceutical products in India is significant and is driven by low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration etc. The role of Indian bulk drug manufacturers in the global pharmaceutical supply chain is gradually evolving with increasing presence in synthesis and manufacture of late-stage intermediates and APIs. Globally, India ranks third in terms of manufacturing Pharma products by volume. India is having very good engineering & research scientist pool and long proven expertise of producing quality bulk drugs. The API market has a fast-progressing growth and there is ample opportunity in indigenous as well as export market. With an ever-changing market scenario influenced by the impending new patent laws and the opening up of international trade, the companies are undergoing a continuous process of diversification these days. And it has to be seen how the industry is going to survive this period of transition and attain its critical mass, which has to serve as one of the crucial factors for its future growth.